Associations between methamphetamine use disorder and <i>SLC18A1</i> , <i>SLC18A2</i> , <i>BDNF</i> , and <i>FAAH</i> gene sequence variants and expression levels

<i>SLC18A1</i> is identified for the first time to play a potential role in methamphetamine use disorder. Lower levels of blood <i>SLC18A2</i> and <i>FAAH</i> mRNA in people with methamphetamine use disorder suggest reduced monoamine reuptake, recycling, or release, and higher anandamide levels in this clinical group, which may be potential therapeutic targets.

Authors

Institutions

Publication Details

Journal
Dialogues in Clinical Neuroscience
Published
2024-10-12
DOI
https://doi.org/10.1080/19585969.2024.2413476
Citations
4
Primary Topic
Neurotransmitter Receptor Influence on Behavior
Type
article
Field-Weighted Citation Impact
1.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Associations between methamphetamine use disorder and SLC18A1 , SLC18A2 , BDNF , and FAAH gene sequence variants and expression levels

Zoe Liu, Andrew J. Lawrence, Briana Spolding, Trang T. T. Truong et al.
4 citations
Dialogues in Clinical Neuroscience
Neurotransmitter Receptor Influence on Behavior
1.07
article

Associations between methamphetamine use disorder and SLC18A1 , SLC18A2 , BDNF , and FAAH gene sequence variants and expression levels

Zoe Liu, Andrew J. Lawrence, Briana Spolding, Trang T. T. Truong, Courtney Swinton, Alexandre A. Guerin, Eric J. Nestler, Yvonne Bonomo, Ken Walder, Susan Lee Rossell, Kiymet Bozaoglu, Michael Berk, Brian Dean, Jee Hyun Kim, Peter J. Hamilton, Bryan R. Parry
article en
4 citations

Abstract

<i>SLC18A1</i> is identified for the first time to play a potential role in methamphetamine use disorder. Lower levels of blood <i>SLC18A2</i> and <i>FAAH</i> mRNA in people with methamphetamine use disorder suggest reduced monoamine reuptake, recycling, or release, and higher anandamide levels in this clinical group, which may be potential therapeutic targets.

Dialogues in Clinical NeuroscienceVol. 26(1)
Allen Institute for Brain Science (US), Barwon Health (AU), Royal Women's Hospital (AU), Deakin University (AU), The University of Melbourne (AU), Virginia Commonwealth University (US), Florey Institute of Neuroscience and Mental Health (AU), St Vincent's Hospital Melbourne (AU), Orygen (AU), Murdoch Children's Research Institute (AU), Swinburne University of Technology (AU), Icahn School of Medicine at Mount Sinai (US)
Medical Research Council, National Health and Medical Research Council
Openalex Percentile: Top 24%
Neurotransmitter Receptor Influence on Behavior
1.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.